Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?
We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Read more >>